BioLineRx Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -1263%. Total operating expenses were $50,802,000.

Profit Margin

BioLineRx Ltd. (NASDAQ:BLRX): Profit margin
2014 0 -10.17M
2015 0 -14.4M
2016 0 -15.84M
2017 0 -24.35M
2018 0 -18.50M
2019 0 -26.80M
2020 0 -30.93M
2021 0 -28.14M
2022 0 -18.87M
2023 4.8M -60.61M -1262.79%

BLRX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
4.8M000000000
Cost of revenue
3.69M654K702K934K940K0480.67K0440.89K0
Gross profit
1.10M-654K-702K-934K-940K0-480.67K0-440.89K0
Operating exp.
Research and development
12.51M17.62M19.46M18.17M23.43M19.80M19.51M11.17M11.48M10.89M
Selling and marketing
14.59M6.46M1.00M840K857K1.36M1.69M1.35M1.00M1.45M
Total operating expenses
50.80M29.15M24.77M22.92M28.11M25.60M25.24M16.51M16.19M15.85M
Operating income
-49.69M-29.15M-24.77M-22.92M-28.11M-25.60M-25.24M-16.51M-16.19M-15.85M
Other income (expenses), net
-10.92M4.20M-2.27M-7.09M2.66M2.64M888K206K1.79M6.17M
Income before tax
-60.61M-24.95M-27.05M-30.02M-25.44M-22.96M-24.35M-15.84M-14.4M-10.17M
Income tax expense
1K-6.07M1.09M911K1.36M-4.45M-888K-672K-1.79M-5.67M
Net income
-60.61M-18.87M-28.14M-30.93M-26.80M-18.50M-24.35M-15.84M-14.4M-10.17M
Earnings per share
Basic EPS
-0.94-0.37-0.64-1.84-2.75-2.56-4.06-4.23-4.2-4.71
Diluted EPS
-0.94-0.37-0.64-1.84-2.75-2.56-4.06-4.23-4.2-4.71
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source